These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8943790)

  • 1. 17 beta-hydroxysteroid oxidoreductase activity in intact cells significantly differs from classical enzymology analysis.
    Castagnetta LA; Granata OM; Taibi G; Lo Casto M; Comito L; Oliveri G; Di Falco M; Carruba G
    J Endocrinol; 1996 Sep; 150 Suppl():S73-8. PubMed ID: 8943790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12).
    Fournier MA; Poirier D
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):142-5. PubMed ID: 18817841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
    Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D
    Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role, control and expression of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase activities in human breast cancer.
    Pasqualini JR
    Zentralbl Gynakol; 1997; 119 Suppl 2():48-53. PubMed ID: 9361395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative and reductive pathways of estrogens in hormone responsive and non-responsive human breast cancer cells in vitro.
    Castagnetta LA; Granata OM; Farruggio R; Cannella S; Montesanti A; Oliveri G; Sorci C; Mesiti M; Carruba G
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):367-74. PubMed ID: 7626482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Org OD14 (Livial) and its metabolites on 17 beta-hydroxysteroid dehydrogenase activity in hormone-dependent MCF-7 and T-47D breast cancer cells.
    Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
    Anticancer Res; 1999; 19(1A):261-7. PubMed ID: 10226552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
    Hevir-Kene N; Rižner TL
    Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17Beta-hydroxysteroid dehydrogenases in human endometrium and its disorders.
    Ito K; Utsunomiya H; Suzuki T; Saitou S; Akahira J; Okamura K; Yaegashi N; Sasano H
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):136-40. PubMed ID: 16406263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer.
    Purohit A; Tutill HJ; Day JM; Chander SK; Lawrence HR; Allan GM; Fischer DS; Vicker N; Newman SP; Potter BV; Reed MJ
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):199-203. PubMed ID: 16414180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
    Laplante Y; Cadot C; Fournier MA; Poirier D
    Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
    Couture P; Thériault C; Simard J; Labrie F
    Endocrinology; 1993 Jan; 132(1):179-85. PubMed ID: 8380373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17 beta-Hydroxysteroid dehydrogenase activity in endometrial cancer cells: different metabolic pathways of estradiol in hormone-responsive and non-responsive intact cells.
    Castagnetta LA; Montesanti AM; Granata OM; Oliveri G; Sorci CM; Amodio R; Liquori M; Carruba G
    J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):573-9. PubMed ID: 8547184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
    Jansson AK; Gunnarsson C; Cohen M; Sivik T; Stål O
    Cancer Res; 2006 Dec; 66(23):11471-7. PubMed ID: 17145895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.
    Aka JA; Mazumdar M; Lin SX
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):183-90. PubMed ID: 19038308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
    Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
    Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer.
    Smuc T; Rupreht R; Sinkovec J; Adamski J; Rizner TL
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):114-7. PubMed ID: 16337331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.